RegionInternational. Neutral scientific reference — not offered for sale here.
Cart · 0
Set region
Explore  /  Oxytocin
Research reference — not for sale

Oxytocin

A
lead outcome
Labor induction / uterotonic / postpartum…
grades vary by outcome ↓
Peptide
also called — Oxytocin · OXT · trade names Pitocin (IV/IM), Syntocinon (nasal, outside US)
(approved:) labor induction / uterotoniclactation(investigational/hyped:) social bonding / trust / empathyautismanxiety / PTSD / addiction

The "love hormone" — approved for childbirth, hyped for everything social, and a textbook replication-crisis story. Oxytocin is a real, approved drug and one of the most over-hyped molecules in popular science. Three threads: (1) as Pitocin, synthetic oxytocin is a genuinely FDA-approved obstetric drug (labor induction, postpartum bleeding) — solid, narrow, real; (2) its fame as the "love/bonding/trust hormone" rests on social-neuroscience findings, many of which failed to replicate; (3) after decades of autism research — including the large SOARS-B trial — intranasal oxytocin has not shown consistent clinical benefit. The gap between the icon and the evidence is the whole entry.

In brief

Oxytocin is a 9-amino-acid endogenous hormone with two lives. As a peripheral hormone, it drives uterine contraction and milk let-down — and synthetic oxytocin (Pitocin) is a genuinely FDA-approved obstetric drug for labor induction and postpartum bleeding. As a central neurotransmitter, it shapes maternal and social bonding — which made it famous as the "love/trust/cuddle hormone." That fame outran the data: many marquee human findings (oxytocin boosting trust or empathy/"mind-reading") failed to replicate, and oxytocin became a symbol of the replication crisis. Its biggest therapeutic hope, autism, has largely disappointed — the large SOARS-B trial found no benefit, and a 2022 NEJM editorial summed it up as "down, but not out." Add genuine uncertainty about how much intranasal oxytocin even reaches the brain, and the honest picture is: a real, important, approved hormone for childbirth — and a much-hyped, inconsistently-supported one for the social/emotional uses it's mostly sold and celebrated for. Big, real biology; approved for one thing; oversold for another.

Legal standing, by region
European Union
Approved / prescription

approved as an obstetric drug (oxytocin/carbetocin); Syntocinon nasal spray available in some countries; social/psychiatric uses investigational.

United States
Approved / prescription

FDA-approved as Pitocin (IV/IM) for obstetric use; the nasal spray is not currently marketed in the US (withdrawn 1995). Intranasal oxytocin for social/psychiatric uses is investigational / off-label / compounded.

Evidence, by outcome
How we grade →

An honest grade per outcome — drawn from the evidence, not any catalogue. Hype and undemonstrated marketing claims grade low.

OutcomeEvidence base · effectGrade
Labor induction / uterotonic / postpartum hemorrhage (the approved use)
Real, established medicine — but a hospital obstetric drug, nothing to do with the "bonding" uses it's sold for; misuse is dangerous
FDA-approved (Pitocin); decades of obstetric use; clear OTR→myometrial-contraction mechanism
A
Lactation / milk let-down
Withdrawn in US for commercial (not efficacy) reasons; still used in some countries
Historically approved (Syntocinon nasal)
B
Social bonding / trust / empathy (healthy people — the "love hormone" claims)
The replication-crisis core: early trust/"mind-reading" results didn't hold up; underpowered studies + publication bias
Strong animal data; human findings largely failed to replicate; effect sizes small
D
Autism spectrum disorder (social deficits)
"Down, but not out" — inconsistent, unreplicated; possible subgroup/dose signals unproven
Decades of RCTs; SOARS-B (large, Phase 2): no benefit; meta-analyses heterogeneous (I²≈93%)
D
PTSD / anxiety / addiction / social anxiety
Early, mixed; nothing established
Preliminary human studies
F
Safety
Obstetric IV: risk of uterine hyperstimulation, fetal distress, water intoxication at high/prolonged doses. Intranasal in trials: generally well-tolerated short-term; brain delivery uncertain
Extensive obstetric + research exposure
Disclosure

Vallydia sells its own cosmetic serums, and some ingredients graded here belong to the same categories as those products. Grades are drawn from the published evidence by the method we publish, and applied to our own ingredients on the same terms — our copper-peptide serum is graded no more kindly than the peptides it competes with. We disclose the interest so you can weigh it.

Trade names shown here (for example Matrixyl, Argireline, Syn-Ake) are the property of their respective owners and are used only to identify the ingredient under discussion. Their appearance implies no affiliation with, or endorsement by, the proprietor.

Evidence changes

Get notified if this changes

We track new research and update these grades as the evidence moves. Leave your email and we'll tell you if the evidence for Oxytocin changes - nothing else.

One ingredient, one purpose. No marketing, no sharing. Unsubscribe anytime. See our privacy policy.

Identity

a 9-amino-acid cyclic peptide (with a disulfide bridge) that is both a hormone and a central neurotransmitter. It's made in the hypothalamus, stored in and released from the posterior pituitary, and acts through the oxytocin receptor (OTR), a Gq-coupled GPCR. It has two quite separate lives: a peripheral hormonal role (uterine contraction, milk let-down) and a central neuromodulatory role (social/maternal behavior) — and the register distinction between them is essential, because the peripheral role is approved medicine and the central one is mostly hype-outpacing-evidence. (Historically notable: oxytocin was the first peptide hormone ever chemically synthesized — du Vigneaud, Nobel Prize 1955.)

Mechanism (as proposed)

oxytocin acts through the oxytocin receptor (OTR), a Gq/11-coupled GPCR signalling via phospholipase C → IP3 → intracellular Ca²⁺. Peripherally, in the myometrium, this Ca²⁺ rise (plus prostaglandin production) drives uterine contraction — the basis of its labor-inducing action; OTR density rises dramatically toward term (why it works then). It also contracts mammary myoepithelial cells for milk let-down. Centrally, oxytocin released within the brain modulates amygdala, reward, and social-cognition circuits, influencing maternal behavior, pair-bonding, social salience, and fear/trust processing — robustly in animal models. The translational problem is that central human effects are small, context-/genotype-dependent (OXTR variants), and inconsistently replicated, and intranasal delivery to the brain is itself uncertain — so the elegant "give oxytocin → more bonding/less social deficit" logic hasn't reliably materialized in human trials.

Chemical identifiers

Cross-reference identifiers for the authoritative external databases — not a recipe, and nothing about how to use it.

PubChem CID439302
InChIKeyXNOPRXBHLZRZKH-DSZYJQQASA-N
SMILESCC[C@H](C)[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N1)CC2=CC=C(C=C2)O)N)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N

via PubChem exact-name match (Oxytocin) · high confidence

Sources — 4 cited
01FDA labeling — oxytocin (Pitocin) for labor induction/augmentation and postpartum hemorrhage; Syntocinon nasal (milk let-down, US withdrawal 1995).
02Replication-crisis literature: failures to replicate intranasal-oxytocin effects on trust and mind-reading in healthy adults; underpowering/publication-bias critiques (e.g. Scientific Reports 2021).
03Autism: SOARS-B (Sikich et al., NEJM 2021) — no benefit; NEJM editorial 2022 "down, but not out"; meta-analyses (Front Psychiatry 2025, I²≈93%); Current Opinion in Neurobiology 2025 review (no consistent clinical benefit).
04Mechanism/obstetrics reviews (OTR/Gq/PLC/Ca²⁺, myometrium); du Vigneaud synthesis (Nobel 1955). (Social/psychiatric uses investigational; not approved.)
Updated 2026-07-13 (watch: OXTR-genotype-stratified / precision-medicine trials and any dose/subgroup autism signal — the field's remaining hope after SOARS-B)

Grades reflect the published evidence, not our interest. No dosing, reconstitution, or administration is published for research compounds — that restraint is deliberate.

Related compounds
VIP (Vasoactive Intestinal Peptide)A
Peptide
Kisspeptin-10 (KP-10)B
Peptide
PT-141 (Bremelanotide)B
Peptide
Afamelanotide (Scenesse / Melanotan-1)A
Peptide
Melanotan IIC
Peptide
Explore by goal
Neuro & cognitiveAnti-inflammatorySleep & circadianReproductiveSkin & aesthetic
Vallydia

A neutral reference and a lawful-lane shop. Information for those who seek it — never promotion.

RegionInternational
ExploreRegisterThe Register — full indexCategoriesTrust & COAHow we gradeOpen dataBrands
ShopCosmetic peptidesJournalQuizzes
TermsPrivacyCookiesReturnsShippingImprint

This site provides neutral scientific reference and sells only products lawful in your region. Nothing here is medical advice, a recommendation, or an offer to supply unapproved medicines. No dosing or administration is published for research compounds. Cosmetic peptides per Regulation (EC) 1223/2009. Unapproved injectable peptides are neither sold nor advertised in the EU (Directive 2001/83/EC, Title VIII). © 2026 Vallydia.